Skip to content

CIK 0001008586

STRM STREAMLINE HEALTH SOLUTIONS INC.

Insider trading from SEC Form 4. Last filing Aug 14, 2025.

STREAMLINE HEALTH SOLUTIONS INC. (STRM) has 23 SEC Form 4 filings on file from 9 insiders, the latest filed on Aug 14, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company

Signals

Open-market buys and sells at STREAMLINE HEALTH SOLUTIONS INC., scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

Every row filed, 41 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Aug 12, 2025Wendy L Lovvorn
Chief People Officer
DDisposition to issuer
Common Stock, $0.01 par value
-27,216--0Aug 14, 2025
Aug 12, 2025Matthew Etheridge
director
DDisposition to issuer
Common Stock, $0.01 par value
-30,876--0Aug 14, 2025
Aug 12, 2025Benjamin Louis Stilwill
President and CEO
DDisposition to issuer
Common Stock, $0.01 par value
-36,849--0Aug 14, 2025
Aug 12, 2025Judith Starkey
director
DDisposition to issuer
Common Stock, $0.01 par value
-75,820--0Aug 14, 2025
Aug 12, 2025Bryant J Reeves III
Chief Financial Officer
DDisposition to issuer
Common Stock, $0.01 par value
-13,515--0Aug 14, 2025
Aug 12, 2025Jonathan R Phillips
director
DDisposition to issuer
Common Stock, $0.01 par value
-96,278--0Aug 14, 2025
Aug 12, 2025Kenan Lucas
director
JOther
Common Stock, $0.01 par valueindirect: See footnote
-321,614$5.34$1.7M0Aug 14, 2025
Aug 12, 2025Wyche T Green III
Executive Chairman
DDisposition to issuer
Common Stock, $0.01 par value
-79,437--0Aug 14, 2025
Aug 12, 2025Justin John Ferayorni
director
DDisposition to issuer
Common Stock, $0.01 par value
-78,416--0Aug 14, 2025
Aug 12, 2025Wyche T Green III
Executive Chairman
DDisposition to issuer
Common Stock, $0.01 par valueindirect: Refer to footnote
-69,845--0Aug 14, 2025
Aug 12, 2025Kenan Lucas
director
JOther
Common Stock, $0.01 par valueindirect: See footnote
-16,666$5.34$89k0Aug 14, 2025
Aug 12, 2025Jonathan R Phillips
director
DDisposition to issuer
Common Stock, $0.01 par valueindirect: Refer to footnote
-4,833--0Aug 14, 2025
Aug 12, 2025Justin John Ferayorni
director
DDisposition to issuer
Common Stock, $0.01 par valueindirect: Refer to footnote
-92,294--0Aug 14, 2025
Aug 12, 2025Benjamin Louis Stilwill
President and CEO
DDisposition to issuer
Common Stock, $0.01 par valueindirect: Includes shares owned by spouse.
-3--0Aug 14, 2025
Aug 12, 2025Matthew Etheridge
director
DDisposition to issuer
Warrant (right to buy)derivative
-61,403--0Aug 14, 2025
Aug 12, 2025Wyche T Green III
Executive Chairman
DDisposition to issuer
Warrant (right to buy)derivativeindirect: Refer to footnote
-59,829--0Aug 14, 2025
Aug 12, 2025Jonathan R Phillips
director
DDisposition to issuer
Warrant (right to buy)derivative
-2,991--0Aug 14, 2025
Aug 12, 2025Justin John Ferayorni
director
DDisposition to issuer
Warrant (right to buy)derivativeindirect: Refer to footnote
-29,914--0Aug 14, 2025
Jul 18, 2025Wyche T Green III
Executive Chairman
FTax withholding
Common Stock, $0.01 par value
-7,008$5.29$37k79,437Jul 29, 2025
Jul 18, 2025Wyche T Green III
Executive Chairman
FTax withholding
Common Stock, $0.01 par value
-6,919$5.30$37k79,526Jul 22, 2025
May 20, 2025Wyche T Green III
Executive Chairman
FTax withholding
Common Stock, $0.01 par value
-1,168$2.26$2,64086,445May 23, 2025
May 20, 2025Wendy L Lovvorn
Chief People Officer
FTax withholding
Common Stock, $0.01 par value
-794$2.26$1,79427,216May 23, 2025
Apr 29, 2025Wendy L Lovvorn
Chief People Officer
FTax withholding
Common Stock, $0.01 par value
-1,156$2.93$3,38728,010May 1, 2025
Apr 29, 2025Bryant J Reeves III
Chief Financial Officer
FTax withholding
Common Stock, $0.01 par value
-1,156$2.93$3,38713,515May 1, 2025
Apr 29, 2025Benjamin Louis Stilwill
President and CEO
FTax withholding
Common Stock, $0.01 par value
-1,264$2.93$3,70436,849May 1, 2025
Nov 10, 2024Bryant J Reeves III
Chief Financial Officer
FTax withholding
Common Stock, $0.01 par value
-63$2.58$16315,114Apr 18, 2025
Nov 1, 2024Wyche T Green III
Executive Chairman
FTax withholding
Common Stock, $0.01 par value
-383$2.30$88189,155Apr 18, 2025
Nov 1, 2024Wendy L Lovvorn
Chief People Officer
FTax withholding
Common Stock, $0.01 par value
-317$2.30$72930,476Apr 18, 2025
Nov 1, 2024Benjamin Louis Stilwill
President and CEO
FTax withholding
Common Stock, $0.01 par value
-628$2.30$1,44440,143Apr 18, 2025
Apr 1, 2025Wyche T Green III
Executive Chairman
FTax withholding
Common Stock, $0.01 par value
-1,542$2.72$4,19487,613Apr 18, 2025
Apr 1, 2025Wendy L Lovvorn
Chief People Officer
FTax withholding
Common Stock, $0.01 par value
-1,310$2.72$3,56329,166Apr 18, 2025
Feb 14, 2025Benjamin Louis Stilwill
President and CEO
FTax withholding
Common Stock, $0.01 par value
-766$3.67$2,81139,377Apr 18, 2025
Dec 4, 2024Bryant J Reeves III
Chief Financial Officer
FTax withholding
Common Stock, $0.01 par value
-327$2.94$96114,787Apr 18, 2025
Apr 1, 2025Bryant J Reeves III
Chief Financial Officer
FTax withholding
Common Stock, $0.01 par value
-116$2.72$31614,671Apr 18, 2025
Apr 1, 2025Benjamin Louis Stilwill
President and CEO
FTax withholding
Common Stock, $0.01 par value
-1,264$2.72$3,43838,113Apr 18, 2025
Nov 13, 2024Justin John Ferayorni
director
IDiscretionary transaction
Common Stock, $0.01 par value
-236,430$0.00$0200,624Nov 22, 2024
Jul 18, 2024Wyche T Green III
Executive Chairman
JOther
Common Stock, $0.01 par value
-100,000$0.50$50k1,343,013Nov 1, 2024
Apr 1, 2024Wyche T Green III
Executive Chairman
FTax withholding
Common Stock, $0.01 par value
-23,096$0.48$11k960,583Nov 1, 2024
May 20, 2024Wyche T Green III
Executive Chairman
FTax withholding
Common Stock, $0.01 par value
-17,570$0.31$5,447943,013Nov 1, 2024
Jul 18, 2024Wyche T Green III
Executive Chairman
AGrant or award
Common Stock, $0.01 par value
+200,000$0.50$100k1,143,013Nov 1, 2024
Jul 18, 2024Wyche T Green III
Executive Chairman
AGrant or award
Common Stock, $0.01 par value
+300,000$0.50$150k1,443,013Nov 1, 2024

Insiders

Everyone who has filed a Form 4 here.

Questions about STRM

Answered from the filings on this page, as of the latest one.

Are insiders buying STRM?

No. In the last 90 days no insider at STREAMLINE HEALTH SOLUTIONS INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade STRM on the open market?

No open-market trade has been scored at STREAMLINE HEALTH SOLUTIONS INC.. The latest Form 4 on file was filed on Aug 14, 2025 and holds grants, exercises or other rows that are not market trades.

How many insiders file Form 4 at STREAMLINE HEALTH SOLUTIONS INC.?

9 people have filed a Form 4 at STREAMLINE HEALTH SOLUTIONS INC., among them Matthew Etheridge (director), Justin John Ferayorni (director), Wyche T Green III (Executive Chairman). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

STRM insider trading: STREAMLINE HEALTH SOLUTIONS INC. | InsiderTell